Current partner codePEPTIDESDE
NCT06256198·Not applicable·OBSERVATIONAL

Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients

Status

Unknown

Phase

Not applicable

Enrollment

80

Locations

0

Results

Not posted

Publications

0

Study summary

What the protocol is testing.

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, if not recognized early and managed promptly, it can lead to septic shock, multiple organ failure and death. Sepsis is associated with high mortality, and the early recognition of the signs of tissue hypo perfusion is crucial in its management. This prospective study was aimed to detect that PCO2 gap can be taken as a reliable prognostic tool in septic patients

Full detailed description

In the community setting, sepsis often presents as the clinical deterioration of common and preventable infections. Sepsis also frequently results from infections acquired in health care settings, which are one of the most frequent adverse events during care delivery and affect hundreds of millions of patients worldwide every year The venous-to-arterial carbon dioxide difference (Pv-aCO2) can indicate the adequacy of microvascular blood flow in the early phases of resuscitation in sepsis. Hence, other resuscitation goals, such as PCO2 gap, have been suggested, due to their ability to predict adverse clinical outcomes and simplicity in patients achieving normal oxygen-derived parameters during the early phases of resuscitation in septic shock. Blood lactate level is also useful in evaluating sepsis. Serum lactate is a good indicator of the presence of hypoxic tissue during septic shock, since its production takes place during Anerobic metabolism. Procalcitonin (PCT) is the precursor of calcitonin, and higher levels are associated with the development of sepsis. Com¬monly, there is an elevation of PCT levels 4 h after the on¬set of symptoms, peaking between 8 h and 24 h.

Interventions

Treatment arms and agents.

OTHER

measurement of serum lactate and procalcitonin and PCO2 gap

measurement of serum lactate, procalcitonin and PCO2 gap

Timeline

From registration to results.

  1. First posted

    Feb 13, 2024

  2. Study start

    Feb 2024

  3. Primary completion

    May 2024

  4. Study completion

    Jun 2024

  5. Results posted

    Not reported

  6. Registry updated

    Feb 13, 2024

Outcomes

What the study measures.

Primary outcomes

prediction of clinical outcome in ICU septic patients

Time frame · 48 hours

PCO2 gap mmHg will be measured on admission and after 48 hours

Secondary outcomes

Not reported in the indexed record.

Eligibility

Who can take part.

Minimum age
18 Years
Maximum age
70 Years
Sex
ALL
Healthy volunteers
No

Inclusion Criteria: * Adult septic patients ≥ 21 years old Exclusion Criteria: * Patients with history of chronic obstructive pulmonary disease and bronchial asthma.

Study locations

0 registered sites.

No country data reported. Showing up to 24 locations stored in the fast local snapshot.

No study locations reported.

Publications

Results and literature.

No PMID-linked publications were present in this registry snapshot.

Primary links

Continue at the source.

Related trials

More studies on Calcitonin.

Related PeptideStat pages

Put the record in context.

Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.